Skip to main content
Effect of dopaminergic medications on BOLD variability and functional connectivity in Parkinson's disease. Brain connectivity Day, T. K., Madhyastha, T. M., Lee, A., Zabetian, C. P., Montine, T. J., Grabowski, T. 2019

Abstract

Both functional connectivity (FC) and blood oxygen level-dependent (BOLD) signal variability (SDBOLD) are methods to examine the physiological state of the brain. Although they are derived from signal changes and are related, few studies have explored their relationship. Here, we examined the relationship between SDBOLD and FC within the default mode network (DMN) in participants with Parkinson's disease ON and OFF dopaminergic medications. Dopaminergic medications had profound effects on both DMN FC and SDBOLD measured separately. Analyzing DMN FC and SDBOLD in a joint independent component analysis, we identified joint components of DMN FC and SDBOLD that were separately associated with measurements of motor and cognitive impairment. Dopaminergic medications had a differential effect on these components depending on these measures of disease severity, "normalizing" the relationships. Importantly, we show that dopaminergic medication status matters in imaging PD; and can affect both connectivity and SDBOLD. Imaging PD ON may lead to inflated estimates of SDBOLD and diminish the ability to measure changes associated with declining motor and cognitive capacities.

View details for DOI 10.1089/brain.2019.0677

View details for PubMedID 31131605